Tevogen Bio Holdings Inc.
FRC CoverageTevogen Bio Holdings Inc.
FRC CoverageYour view on TVGN
Overview
What the company does, where it operates, and who runs it.
*Tevogen Bio Holdings Inc. has paid FRC a fee for research coverage and distribution of reports.
About Tevogen Bio Holdings Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Ryan H. Saadi M.P.H,
- Headquarters
- 15 Independence Boulevard Suite #410, Warren, NJ, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Ryan H. Saadi M.P.H,
- Headquarters
- 15 Independence Boulevard Suite #410, Warren, NJ, US
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment.
Fast Tracking a Potential Breakthrough for Treating Viral Infections and Cancer
Sign in to view
Fast Tracking a Potential Breakthrough for Treating Viral Infections and Cancer
Sign in to view
Infographics
Visual summary of the business at a glance.
Research Reports
FRC analyst coverage and recommendations.
Past Reports
Historical coverage archive.
Analyst Notes
Ongoing commentary and updates from FRC analysts.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.